Pet Medications in the US, 9th Edition

A focus on pet health and wellness has driven growth in the pet medications market in the US even as economic challenges have dampened consumer spending in the market. The US market for pet medications for dogs and cats reached $12.6 billion in 2024 and is projected to grow at a moderate pace through 2029. Growth is dependent upon a return to financial stability, a recovery in the dog population, and a continued interest in the part of pet owners in maintaining their pets’ health and wellness.

This report covers pet medications for dogs and cats by animal type, product type, and sales channel.

Sales by product are presented for:
Parasticides
Vaccines
Anti-infectives
Pain medication
All other

Parasiticide sales are broken out for:
Prescription products vs. over-the-counter products
Flea/tick
Heartworm
Combination flea/tick/heartworm

Sales by channel are presented for:
Veterinary channel
E-commerce
Pet specialty
Mass market
All other


Scope of the report:
This report examines the $12.6 billion market for pet medications for dogs and cats, with a focus on products purchased directly by consumers. These include both prescription and over-the-counter (also called OTC or retail) medications. The primary focus of this report is on the core types of antiparasitics/parasiticides – heartworm preventatives, flea/tick preventatives, and heartworm/flea combo products, and other dewormers (some of which also target other external parasites such as mosquitoes, flies, ear mites, lice, and sarcoptic mange, and/or other types of internal parasites such as hookworms, roundworms, whipworms, and tapeworms). Also covered are market-shaping developments in other areas, including anxiety, pain management, cancer, cognitive dysfunction, and obesity/diabetes. The report takes a deep dive into key trends in marketing and new products, retail channel trends, and consumer trends. Consumer data comes from Packaged Facts’ proprietary Surveys of Pet Owners and includes purchase rates by product type and by channel, demographic data, and psychographics exploring purchase attitudes and motivations. Historical data are provided for 2019 through 2024, with projections for 2025 through 2029.
Show more